Long Noncoding RNA IRAIN Drives Immunometabolic Reprogramming in Glioma via the IGF1R-JAK-STAT-BIRC5 Axis
Journal of Visualized Experiments · 2025
DOI: 10.3791/69711 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2025. Written by Ai-Shun Guo and 5 co-authors. Institution: Department of Neurosurgery, Zhangzhou Municipal Hospital of Fujian Province and Zhangzhou Affiliated Hospital of Fujian Medical University; 152606031…. Major MEDLINE topics: Glioma, RNA, Long Noncoding, Brain Neoplasms. 38 references.
Abstract (original language)
Glioma is an aggressive malignancy with limited therapeutic options and a poor prognosis. Its progression is closely linked to metabolic reprogramming and immune evasion, underscoring the need to identify molecular regulators that integrate these processes. Here, we established a robust immunometabolic-related gene (IMRG) prognostic signature and elucidated the role of the long noncoding RNA IRAIN in regulating glioma immunometabolism through the IGF1R-JAK-STAT-BIRC5 axis. Transcriptomic and clinical data from TCGA, CGGA (693/325), and GEO (GSE43378) cohorts were analyzed. Differential expression and weighted gene co-expression network analysis (β = 8) ensured scale-free topology, and a leave-one-out cross-validation framework combining ten machine-learning algorithms produced 101 prognostic models. The optimal 17-gene IMRG signature was validated across all cohorts and independently predicted overall survival. Functional assays demonstrated that IRAIN overexpression inhibited IGF1R, suppressed JAK2/STAT3 phosphorylation, and downregulated BIRC5, thereby promoting apoptosis and reducing angiogenesis. Low IRAIN expression correlated with immunosuppressive Tregs and M2 macrophages and with elevated tumor-microenvironment scores, suggesting an immune-evasive phenotype. These findings establish IRAIN as a key regulator of glioma immunometabolic reprogramming and validate the IMRG signature as a reliable prognostic tool, highlighting the IRAIN-IGF1R-JAK-STAT-BIRC5 pathway as a mechanistic bridge linking immune and metabolic dysregulation in glioma and offering potential targets for precision therapy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Neurosurgery, Zhangzhou Municipal Hospital of Fujian Province and Zhangzhou Affiliated Hospital of Fujian Medical University; 1526060316@163.com.
- The School of Clinical Medicine, Fujian Medical University, Zhangzhou Affiliated Hospital of Fujian Medical University.
- Department of Neurosurgery, Zhangzhou Municipal Hospital of Fujian Province and Zhangzhou Affiliated Hospital of Fujian Medical University.
- Department of Neurosurgery, Zhangzhou Municipal Hospital of Fujian Province and Zhangzhou Affiliated Hospital of Fujian Medical University; 15396061261@163.com.
Cite
APA
Guo, A. S., Lin, H., Lin, P. W., Wang, Y. Z., Lin, Z. R., & Wang, W. W. (2025). Long Noncoding RNA IRAIN Drives Immunometabolic Reprogramming in Glioma via the IGF1R-JAK-STAT-BIRC5 Axis. Journal of Visualized Experiments. https://doi.org/10.3791/69711
Vancouver
Guo AS, Lin H, Lin PW, Wang YZ, Lin ZR, Wang WW. Long Noncoding RNA IRAIN Drives Immunometabolic Reprogramming in Glioma via the IGF1R-JAK-STAT-BIRC5 Axis. Journal of Visualized Experiments. 2025. doi:10.3791/69711
BibTeX
@article{Guo2025,
author = {Guo, Ai-Shun and Lin, Hong and Lin, Peng-Wei and Wang, Yu-Zhe and Lin, Zhen-Rong and Wang, Wei-Wei},
title = {Long Noncoding RNA IRAIN Drives Immunometabolic Reprogramming in Glioma via the IGF1R-JAK-STAT-BIRC5 Axis},
journal = {Journal of Visualized Experiments},
year = {2025},
doi = {10.3791/69711}
}
EUVIMED